Logo for Immix Biopharma Inc

Immix Biopharma Investor Relations Material

Latest events

Logo for Immix Biopharma

Q4 2024

25 Mar, 2025
Logo for Immix Biopharma

Investor Presentation

20 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Immix Biopharma Inc

Access all reports
Immix Biopharma Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing therapies for cancer and inflammatory diseases. The company’s lead programs are based on its proprietary tissue-specific therapeutics platform, designed to deliver biologics and small molecules to specific tissues while minimizing systemic toxicity. Immix Biopharma conducts clinical trials for rare and hard-to-treat cancers, as well as immune-related conditions. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.